Kraig Biocraft Laboratories (KBLB) Invested Capital (2010 - 2025)

Kraig Biocraft Laboratories has disclosed Invested Capital across 16 years of filings, most recently posting -$8.0 million for Q4 2025.

• Invested Capital for Q4 2025 came in at -$8.0 million, up 1.85% year-over-year; the trailing twelve-month figure through Dec 2025 was -$8.0 million (up 1.85% YoY), and the FY2025 annual result was -$8.0 million, up 1.85% from the prior year.
• Invested Capital came in at -$8.0 million for Q4 2025 at Kraig Biocraft Laboratories, down from -$8.0 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of -$3.4 million in Q4 2022 to a low of -$8.5 million in Q1 2025.
• The 5-year median for Invested Capital is -$5.8 million (2021), against an average of -$5.9 million.
• Across the five-year window, Invested Capital tumbled 162.02% in 2021 and soared 40.9% in 2022, its largest moves.
• Kraig Biocraft Laboratories' Invested Capital stood at -$5.2 million in 2021, then surged by 34.56% to -$3.4 million in 2022, then sank by 65.53% to -$5.7 million in 2023, then slumped by 43.68% to -$8.1 million in 2024, then grew by 1.85% to -$8.0 million in 2025.
• The last three Invested Capital figures came in at -$8.0 million (Q4 2025), -$8.0 million (Q3 2025), and -$8.5 million (Q2 2025), per Business Quant data.